Renovis was listed on NASDAQ in 2003.
Merger with Vectura Group plc (LSE: VEC) in 2016.
Sloning was acquired by Morphosys in 2010.
Sunesis was listed on NASDAQ in 2005.
Symbiomix was acquired by Lupin for $150 million plus contingent payments in 2017.
Syntonix was acquired by Biogen Idec for up to $120 million in 2007.
Syrrx was acquired by Takeda for $270 million in 2005.
TandemLife was acquired by LivaNova (Nasdaq:LIVN) for up to $250 million in 2018.
Assets of Tensys were acquired by a Chinese Company by end of 2017.
Transform was acquired by Johnson & Johnson for $230 million in 2005.
True North Therapeutics was acquired by Bioverativ in 2017 for up to $825 million.
Xenoport was listed on NASDAQ in 2005.
Sale of position to an investor in 2009.
Zycos was acquired by MGI Pharma for $50 million in 2004.